These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 5421482)
1. [The treatment of sea-sickness: thiethylperazine in prophylaxis and therapy]. Rubensohn G Lakartidningen; 1970 Feb; 67(6):619-24. PubMed ID: 5421482 [No Abstract] [Full Text] [Related]
2. Suppression of motion sickness by thiethylperazine (Torecan). Johnson WH; Ireland PE Aerosp Med; 1966 Feb; 37(2):181-3. PubMed ID: 4955725 [No Abstract] [Full Text] [Related]
3. Side effects of some antimotion sickness drugs as measured by psychomotor test and questionnaires. Kennedy RE; Wood CD; Graybiel A; McDonough RB Aerosp Med; 1966 Apr; 37(4):408-11. PubMed ID: 5954449 [No Abstract] [Full Text] [Related]
4. Evaluation of sixteen anti-motion sickness drugs under controlled laboratory conditions. Wood CD; Graybiel A Aerosp Med; 1968 Dec; 39(12):1341-4. PubMed ID: 4881887 [No Abstract] [Full Text] [Related]
5. [Prevention and treatment of the symptom complex in motion sickness]. Esipov IA Voen Med Zh; 1973 Feb; 2():69-71. PubMed ID: 4765549 [No Abstract] [Full Text] [Related]
6. A trial of thiethylperazine ("Torecan") in patients suffering from radiation sickness. Holt JA Med J Aust; 1965 Aug; 2(7):279-81. PubMed ID: 5212598 [No Abstract] [Full Text] [Related]
7. The anti-emetic properties of 1-sulpiride in a ground-based model of space motion sickness. Miller JD; Brizzee KR Life Sci; 1987 Oct; 41(15):1815-22. PubMed ID: 3657384 [TBL] [Abstract][Full Text] [Related]
8. Phenytoin for motion sickness: clinical evaluation. Knox GW; Woodard D; Chelen W; Ferguson R; Johnson L Laryngoscope; 1994 Aug; 104(8 Pt 1):935-9. PubMed ID: 8052077 [TBL] [Abstract][Full Text] [Related]
9. [Therapeutic use and effects of Toresten for radiation sickness]. Tatsuno I Rinsho Hoshasen; 1970 Dec; 15(12):913-5. PubMed ID: 5203529 [No Abstract] [Full Text] [Related]
10. A comparison of effectiveness of some antimotion sickness drugs using recommended and larger than recommended doses as tested in the slow rotation room. NSAM-945. Wood CD; Graybiel A; Kennedy RS Res Rep U S Nav Sch Aviat Med; 1965 Jul; ():1-9. PubMed ID: 5322559 [No Abstract] [Full Text] [Related]
11. [Chronic dyskinesia due to treatment with thiethylperazine (Torecan)]. Ekbom K; Ekstrand T Lakartidningen; 1972 Jan; 69(3):271-3. PubMed ID: 5015409 [No Abstract] [Full Text] [Related]
12. [Acute facial dyskinesia after treatment with thiethylperazine (Torecan)]. Dahlerup B Ugeskr Laeger; 1976 Dec; 138(51):3277-8. PubMed ID: 996966 [No Abstract] [Full Text] [Related]
13. [Use of No-Shpa in combination with vitamins in motion sickness]. Usachev VV; Sabaev VV; Matveev AD; Popov AG Kosm Biol Aviakosm Med; 1981; 15(3):82-3. PubMed ID: 7289553 [No Abstract] [Full Text] [Related]
14. What you thought you knew about motion sickness isn't necessarily so. Cowings PS; Malmstrom FV Flying Saf; 1984 Feb; 40(2):12-7. PubMed ID: 11540877 [TBL] [Abstract][Full Text] [Related]
15. [Motion sickness--where can one turn?]. Frey OR Med Monatsschr Pharm; 2002 Jul; 25(7):244-5. PubMed ID: 12148239 [No Abstract] [Full Text] [Related]
16. [Acute dyskinesia in children treated with thiethylperazine (Torecan)]. Hostrup-Pedersen C; Engbaek J Ugeskr Laeger; 1975 Mar; 137(13):744-5. PubMed ID: 1135970 [No Abstract] [Full Text] [Related]
17. The control of radiation sickness with thiethylperazine (torecan). Johnson EM N Z Med J; 1965 Nov; 64(399):649-50. PubMed ID: 5216066 [No Abstract] [Full Text] [Related]
19. Efficacy of thiethylperazine as a recovery room anti-emetic. Gold MI; Ruy BP Br J Anaesth; 1966 May; 38(5):380-5. PubMed ID: 5328264 [No Abstract] [Full Text] [Related]
20. A double-blind placebo controlled study of cinnarizine in the prophylaxis of seasickness. Hargreaves J Practitioner; 1980 May; 224(1343):547-50. PubMed ID: 6999486 [No Abstract] [Full Text] [Related] [Next] [New Search]